2. Gene
  3. C6 - complement C6 Gene

C6 - complement C6 Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens
Gene ID: 729 | Gene type: protein coding

About C6

Cytogenetic location: 5p13.1 Genomic coordinates (GRCh38): 5:41,142,116-41,261,469 (from NCBI)

This gene has 9 transcripts (splice variants), 206 orthologues, 39 paralogues and is associated with 2 phenotypes. Biased expression in liver (RPKM 126.4), heart (RPKM 11.8) and 2 other tissues.

Summary

This gene encodes a component of the complement cascade. The encoded protein is part of the membrane attack complex that can be incorporated into the cell membrane and cause Cell Lysis. Mutations in this gene are associated with complement component-6 deficiency. Transcript variants encoding the same protein have been described.[provided by RefSeq, Nov 2012]

C6 Products(2)

mRNA Protein Name
NM_000065.5 NP_000056.2 complement component C6 precursor
NM_001115131.4 NP_001108603.2 complement component C6 precursor
Gene Ontology
  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence Reference Source
enables protein binding IPI
IPI: Inferred from physical interaction
17474147 GOA
Biological Process GO Annotation Evidence Reference Source
involved in complement activation IDA
IDA: Inferred from direct assay
2808363 GOA
Cellular Component GO Annotation Evidence Reference Source
part of membrane attack complex IDA
IDA: Inferred from direct assay
22832194 GOA
part of membrane attack complex IPI
IPI: Inferred from physical interaction
30552328 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

C6 Protein Structure

TSP_1

TSP_1: Thrombospondin type 1 domain (28 - 78)

TSP_1

TSP_1: Thrombospondin type 1 domain (86 - 133)

Ldl_recept_a

Ldl_recept_a: Low-density lipoprotein receptor domain class A (140 - 173)

MACPF

MACPF: MAC/Perforin domain (293 - 514)

TSP_1

TSP_1: Thrombospondin type 1 domain (571 - 612)

Sushi

Sushi: Sushi repeat (SCR repeat) (644 - 695)

Sushi

Sushi: Sushi repeat (SCR repeat) (713 - 754)

Kazal_2

Kazal_2: Kazal-type serine protease inhibitor domain (793 - 837)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 934 a.a.
Protein Preferred Names Protein Names

complement component C6

complement component 6

Recombinant C6 Proteins

Cat. No. Product Name Accession Purity
HY-P74373 C6/Complement component C6 Protein, Human (HEK293, His) AAA59668 (C22-A934) ≥95%

Related Diseases

Diseases Alias
Complement Component 6 Deficiency

C6 Deficiency

C6D

C6 Deficiency Subtotal

Complement Component 6 Deficiency Subtotal

C6 Deficiency, Subtotal
Immunodeficiency Due To A Late Component Of Complement Deficiency

Immunodeficiency Due To C5 To C9 Component Complement Deficiency

Terminal Complement Pathway Deficiency
Meningococcal Meningitis

Meningitis, Meningococcal

Meningitis Meningococcal

Epidemic Meningitis

Meningitis Due To Neisseria Meningitidis

Meningococcal Meninges Infection

Meningococcal Meningeal Infection

Meningococcal Cerebrospinal Inflammation

Chronic Meningococcal Arachnoiditis

Meningococcal Arachnoiditis

Diplococcal Spinal Meningitis

Diplococcal Meningitis

Meningococcal Cerebrospinal Fever

Meningococcal Cerebrospinal Infection

Meningococcal Spinal Meningitis
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Approval
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N7140 Gamma-Linolenic acid Inhibitor 99.74% Unkown
Clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-N2037A Higenamine hydrochloride 99.68% Phase 1
HY-N2037 Higenamine 98.91% Phase 1
Pre-clinical Phase
Bioactive Molecules (474)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0389A D-Glucose-13C6 99.92% Unkown
HY-129047 Trypsin Activator / Unkown
HY-19542 C6 Ceramide Inducer 99.78% Unkown
HY-16594 Lactacystin Inhibitor 98.2% Unkown
HY-100014 KDM5A-IN-1 Inhibitor 99.80% Unkown
HY-D0180 18-Crown-6-ether 99.57% Unkown
HY-N7092S D-Fructose-13C6 99.95% Unkown
HY-140921 Biotin-PEG4-amino-t-Bu-DADPS-C6-azide ≥95.0% Unkown
HY-W011561 Boc-NH-C6-Br ≥98.0% Unkown
HY-N1127 Tricin Inhibitor 99.87% Unkown
HY-107836 Methiothepin mesylate Antagonist 99.60% Unkown
HY-N0455AS8 L-Arginine-13C6,15N4 hydrochloride Activator ≥99.0% Unkown
HY-145442 8-Azanebularine Inhibitor 98.21% Unkown
HY-N1428S1 Citric acid-13C6 ≥99.0% Unkown
HY-112495 VH032-PEG5-C6-Cl 99.93% Unkown
HY-104036 IDH-305 Inhibitor 98.75% Unkown
HY-140914 Biotin-PEG4-Amide-C6-Azide 99.11% Unkown
HY-N0455AS6 L-Arginine-13C6 hydrochloride Activator 99.00% Unkown
HY-N6974 Ascr#2 ≥98.0% Unkown
HY-W008296 NH2-C6-NH-Boc 99.61% Unkown
HY-129047A Trypsin (MS grade) Activator 95.00% Unkown
HY-140314 DOTA-PEG5-C6-DBCO 96.40% Unkown
HY-138470 Azido-PEG2-C6-Cl ≥95.0% Unkown
HY-112496 Cl-C6-PEG4-O-CH2COOH ≥98.0% Unkown
HY-113410 3-Methylglutaric acid ≥98.0% Unkown
HY-N0470S3 L-Lysine-13C6,15N2 hydrochloride Inhibitor ≥98.0% Unkown
HY-138521 Azido-C6-OH ≥95.0% Unkown
HY-N0379S22 D-Mannose-13C6 ≥98.0% Unkown
HY-N0486S8 L-Leucine-13C6,15N Activator 99.90% Unkown
HY-W356116 C6 NBD Ceramide / Unkown
HY-119402 TP-021 Inhibitor 99.14% Unkown
HY-135250B Thalidomide-4-O-C6-NH2 hydrochloride Inducer 98.53% Unkown
HY-103605 (S,R,S)-AHPC-C6-PEG3-C4-Cl 97.01% Unkown
HY-129622A NH2-PEG5-C6-Cl hydrochloride ≥98.0% Unkown
HY-139218 (S,R,S)-AHPC-Me-C6-NH2 99.14% Unkown
HY-W009762S L-Lysine-13C6,15N2 dihydrochloride 99.40% Unkown
HY-113248S1 3-Nitro-L-tyrosine-13C6 ≥95.0% Unkown
HY-133689AS 3-Nitrophenylhydrazine-13C6 hydrochloride 98.26% Unkown
HY-138469 NH2-PEG3-C6-Cl ≥95.0% Unkown
HY-B0322S1 Sulfamethoxazole-13C6 Inhibitor 99.65% Unkown
HY-N0210S16 D-Galactose-13C6 ≥99.0% Unkown
HY-N0215S8 L-Phenylalanine-13C6 Antagonist ≥99.0% Unkown
HY-N0771S L-Isoleucine-13C6 ≥98.0% Unkown
HY-130951 Thalidomide-O-C6-COOH Inducer 99.67% Unkown
HY-111253 CYM-5478 Agonist 99.90% Unkown
HY-112537S1 D-Glucose 6-Phosphate-13C6 disodium xhydrate ≥98.0% Unkown
HY-121805 DBCO-​C6-​acid 97.52% Unkown
HY-N2038 3,​5,​6,​7,​8,​3',​4'-​Heptemthoxyflavone Inhibitor 99.85% Unkown
HY-N6076 Tenuifoliside A Inhibitor 98.07% Unkown
HY-P3146S FTISADTSK-13C6,15N2 TFA 99.02% Unkown
HY-135306 Cl-C6-PEG4-C3-COOH 99.65% Unkown
HY-138466 Azido-PEG3-C6-Cl ≥95.0% Unkown
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% Unkown
HY-126683 Mal-C6-α-Amanitin 98.48% Unkown
HY-103608 (S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl 99.89% Unkown
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% Unkown
HY-B0143S3 Niacin-13C6 Inducer 98.00% Unkown
HY-B0166S L-Ascorbic acid-13C6 99.65% Unkown
HY-B0389S D-Glucose-13C6,d7 ≥98.0% Unkown
HY-B0400S16 D-Sorbitol-13C6 99.94% Unkown
HY-B0497S1 Niclosamide-13C6 Inhibitor ≥99.0% Unkown
HY-N0473S2 L-Tyrosine-13C6 99.90% Unkown
HY-N0486S2 L-Leucine-13C6 Activator ≥98.0% Unkown
HY-W018291 Mal-C6-amine TFA 98.51% Unkown
HY-18569S4 3-Indoleacetic acid-13C6 ≥98.0% Unkown
HY-148129 TRPC6-IN-3 Inhibitor 99.62% Unkown
HY-108971 Demecycline Inhibitor ≥98.0% Unkown
HY-124377 SPDP-C6-NHS ester 98.09% Unkown
HY-136006B (S,R,S)-AHPC-C6-NH2 98.03% Unkown
HY-141576 C6-NBD Sphinganine ≥99.0% Unkown
HY-144085S D-Fructose-6-phosphate-13C6 disodium x.hydrate 99.90% Unkown
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% Unkown
HY-152039S1 6PPD-quinone-13C6 ≥98.0% Unkown
HY-161536 PROTAC EGFR degrader 9 / Unkown
HY-16938S 5'-Methylthioadenosine-13C6 98.45% Unkown
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% Unkown
HY-D1432 FITC-C6-DEVD-FMK ≥97.0% Unkown
HY-D1574 C6 NBD Sphingomyelin ≥98.0% Unkown
HY-N0098S2 Vanillin-13C6 ≥99.0% Unkown
HY-N0469S1 L-Lysine-13C6 dihydrochloride Inhibitor 98.70% Unkown
HY-N2461 Ganoderic acid C6 98.15% Unkown
HY-W356117 C6 NBD Glucosylceramide ≥98.0% Unkown
HY-159192S SADDNIKTPAE(Arg-13C6,15N4)LLGPLPPSADDNLKT TFA 95.11% Unkown
HY-B0190S1 Nafamostat formate salt-13C6 95.90% Unkown
HY-112618A Thalidomide-O-amido-C6-NH2 TFA Inducer 99.82% Unkown
HY-129704A Thalidomide-NH-C6-NH2 TFA Inducer 99.82% Unkown
HY-130854 Thalidomide-NH-C6-NH-Boc Inducer 96.11% Unkown
HY-136006A (S,R,S)-AHPC-C6-NH2 hydrochloride / Unkown
HY-106950S1 Fosfructose-13C6 tetrasodium hydrate 99.90% Unkown
HY-10715 SSR504734 Inhibitor 99.82% Unkown
HY-108226S1 Regorafenib N-oxide and N-desmethyl (M5)-13C6 ≥91.0% Unkown
HY-108372 Boc-C5-O-C5-O-C6-Cl / Unkown
HY-112499S1 Menaquinone-7-13C6 ≥96.0% Unkown
HY-129704B Thalidomide-NH-C6-NH2 hydrochloride Inducer 99.62% Unkown
HY-130621 OTs-C6-OBn 98.07% Unkown
HY-131887 Pomalidomide-C6-COOH 98.02% Unkown
HY-138622S 24:0 Lyso PC-13C6 97.5% Unkown
HY-141887 Thalidomide-O-C6-NHBoc Inducer 95.07% Unkown
HY-143876S L-Argininosuccinic acid-13C6,15N4 barium, dihydrate 95.7% Unkown
HY-144677 pan-HER-IN-2 98.10% Unkown
HY-147622 GLP-1R agonist 9 Agonist / Unkown
HY-148556 Thalidomide-O-C6-azide Inducer 99.71% Unkown
HY-15036S1 Diclofenac-13C6 99.90% Unkown
HY-18341S2 L-Thyroxine-13C6 91.0% Unkown
HY-90009D (6S,12aR)-Tadalafil Inhibitor 99.34% Unkown
HY-B0035S2 Sulfamethazine-13C6 99.10% Unkown
HY-B0150S2 Nicotinamide-13C6 Inhibitor 99.8% Unkown
HY-B0167S1 Salicylic acid-13C6 ≥97.0% Unkown
HY-B0451AS1 Dopamine-13C6 hydrochloride 98.71% Unkown
HY-B0975S Penicillin V-13C6 potassium Inhibitor 99.8% Unkown
HY-B1221S1 Flufenamic acid-13C6 / Unkown
HY-B1267S1 Sulfaguanidine-13C6 Inhibitor ≥99.0% Unkown
HY-B1703S Nifursol-13C6 Inhibitor 99.60% Unkown
HY-N0384S3 Homovanillic acid-13C6,18O 99.2% Unkown
HY-N0684S3 Vitamin K1-13C6 ≥99.0% Unkown
HY-W014225S 3-Phenoxybenzoic acid-13C6 99.29% Unkown
HY-W014375S2 Arginine-13C6 hydrochloride 99.00% Unkown
HY-W014423S3 L-Histidine-13C6,15N3 hydrochloride hydrate 99.53% Unkown
HY-W017522S1 Adipic acid-13C6 ≥98.0% Unkown
HY-W104010S 2-Chloroaniline hydrochloride-13C6 99.64% Unkown
HY-W129359 11β-HSD1-IN-8 ≥95.0% Unkown
HY-Y0051S 5-Hydroxymethylfurfural-13C6 ≥98.0% Unkown
HY-141939S Triiodothyronine-13C6( hydrochloride) 96.74% Unkown
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% Unkown
HY-B0252S2 Hydrochlorothiazide-13C6 99.61% Unkown
HY-N0349S1 Methyl paraben-13C6 99.90% Unkown
HY-N7032S1 Uridine 5′-diphosphoglucose-13C6 disodium 98.35% Unkown
HY-P3003S Cereulide-13C6 ≥97.0% Unkown
HY-W103245 Benzo-18-crown-6-ether 99.37% Unkown
HY-W782153 Acetophenone-13C6 98.42% Unkown
HY-111543 AN11251 Inhibitor / Unkown
HY-112618 Thalidomide-O-amido-C6-NH2 Inducer / Unkown
HY-129704 Thalidomide-NH-C6-NH2 Inducer / Unkown
HY-135250 Thalidomide-4-O-C6-NH2 Inducer / Unkown
HY-135250A Thalidomide-4-O-C6-NH2 TFA Inducer / Unkown
HY-125884 Pomalidomide-amido-C4-amido-C6-NH-Boc / Unkown
HY-131089 MC-VC-PABC-C6-alpha-Amanitin / Unkown
HY-136006 (S,R,S)-AHPC-C6-NH2 dihydrochloride / Unkown
HY-100532S CD437-13C6 Agonist / Unkown
HY-101009 Methiothepin maleate Antagonist / Unkown
HY-101064S1 Fmoc-leucine-13C6,15N Modulator / Unkown
HY-10163S2 Dabigatran-13C6 / Unkown
HY-10260S2 Vandetanib-13C6 / Unkown
HY-10572S1 Efavirenz-13C6 / Unkown
HY-109120S1 Odevixibat-13C6 Inhibitor / Unkown
HY-10999S1 Trametinib-13C6 / Unkown
HY-111824 VH032-thiol-C6-NH2 / Unkown
HY-112586S1 Sulfaethoxypyridazine-13C6 Inhibitor / Unkown
HY-112618B Thalidomide-O-amido-C6-NH2 hydrochloride Inducer 99.32% Unkown
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / Unkown
HY-113252S1 2-Methoxyestrone-13C6 / Unkown
HY-113296S Indoxyl sulfate-13C6 potassium / Unkown
HY-113410S 3-Methylglutaric acid-d4 / Unkown
HY-114750S Mebendazole-amine-13C6 / Unkown
HY-114895 SSR504734 free base Inhibitor / Unkown
HY-115584S Lufenuron-13C6 Inhibitor / Unkown
HY-116214S1 Cyprodinil-13C6 / Unkown
HY-116609 C6 L-threo Ceramide Inhibitor / Unkown
HY-117042 Biotin-PEG2-C6-azide 95.87% Unkown
HY-117275S1 Meclofenamic acid-13C6 Inhibitor / Unkown
HY-12008S1 Erlotinib-13C6 hydrochloride / Unkown
HY-12033S1 2-Methoxyestradiol-13C6 / Unkown
HY-121267S Dicamba-13C6 / Unkown
HY-122062S Fenoxycarb-13C6 / Unkown
HY-124489S 2-Hydroxyestradiol-13C6 / Unkown
HY-125296S Fipronil sulfone-13C6 / Unkown
HY-125888 Boc-NH-C6-amido-C4-acid / Unkown
HY-126373S1 SN-38 glucuronide-13C6 / Unkown
HY-12726S Liproxstatin-1-13C6 / Unkown
HY-12857S Brigatinib-13C6 Inhibitor / Unkown
HY-128790S1 4-Methoxyestrone-13C6 / Unkown
HY-129622 NH2-PEG5-C6-Cl / Unkown
HY-129656 GLP-1 receptor agonist 3 Agonist / Unkown
HY-129974S 3,3'-Diiodo-L-thyronine-13C6 / Unkown
HY-13078S Cobimetinib-13C6 racemate / Unkown
HY-131501S1 Menaquinone-9-13C6 / Unkown
HY-131682 3-C6-NBD-cholesterol / Unkown
HY-133694S 2-Aminoflubendazole-13C6 / Unkown
HY-13613S Dutasteride-13C6 / Unkown
HY-136380S Clodinafop-propargyl-13C6 / Unkown
HY-13690S1 Mitotane-13C6 / Unkown
HY-137912S1 Resveratrol-3-O-beta-D-glucuronide-13C6 / Unkown
HY-138471 Azido-PEG2-C6-OH / Unkown
HY-138852 Thalidomide-NH-amido-C6-NH2 Inducer / Unkown
HY-138852A Thalidomide-NH-amido-C6-NH2 hydrochloride Inducer / Unkown
HY-139921S1 Nordiazepam-13C6 / Unkown
HY-141123 SPDP-C6-Gly-Leu-NHS ester / Unkown
HY-141315 m-PEG6-C6-phosphonic acid ethyl ester / Unkown
HY-141909S 4-Fluoroiodobenzene-13C6 / Unkown
HY-141919S 1-Bromo-4-iodobenzene-13C6 / Unkown
HY-141928S 4-Bromoanisole-13C6 / Unkown
HY-143276A (S,S,R)-AHPC-C6-NH2 hydrochloride 97.20% Unkown
HY-143830 t-Boc-N-amido-PEG2-C6-Cl / Unkown
HY-143843S Isosorbide-2-mononitrate-13C6 / Unkown
HY-143857S 22:0 Lyso PC-13C6 / Unkown
HY-144825 Chol-CTPP Inducer / Unkown
HY-14538S3 Haloperidol-13C6 Antagonist / Unkown
HY-146002 IDH2R140Q-IN-1 Inhibitor / Unkown
HY-146687 BuChE-IN-4 Inhibitor / Unkown
HY-146966S 2-NP-DNSAH-13C6 / Unkown
HY-146967S 4-(3,6-Dimethylhept-3-yl)phenol-13C6 / Unkown
HY-146968S Alloerythro-Isoxsuprine-13C6 hydrochloride / Unkown
HY-146969S Bisdesoxyquinoceton-13C6 / Unkown
HY-146972S Zearalenone-14-O-β-glucoside-13C6 / Unkown
HY-147178 C-6 NBD-dihydro-Ceramide / Unkown
HY-147516 SARS-CoV-2-IN-21 Inhibitor / Unkown
HY-148143 Pomalidomide-C6-NHS ester / Unkown
HY-148153 C6-Amide-(PEG)n-CH3 / Unkown
HY-148154 Poly(oxy-1,2-ethanediyl)-propoxy-amide-C6 / Unkown
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% Unkown
HY-15027S2 5-Aminosalicylic acid-13C6 / Unkown
HY-15037S Diclofenac-13C6 sodium heminonahydrate / Unkown
HY-15037S2 Diclofenac-13C6 sodium / Unkown
HY-150626 SARS-CoV-2 nsp13-IN-5 Inhibitor / Unkown
HY-150679S Remdesivir-13C6 / Unkown
HY-150703S DL-4-Methoxyestradiol-13C6 / Unkown
HY-150706S D-fructose-6-phosphate-13C6 / Unkown
HY-150978 DDAO-C6 / Unkown
HY-151271 SARS-CoV-2-IN-27 Inhibitor / Unkown
HY-151271A SARS-CoV-2-IN-27 disodium Inhibitor / Unkown
HY-151791 (S,R,S)-AHPC-C6-PEG3-butyl-N3 / Unkown
HY-15284S3 Prasugrel-13C6 Inhibitor / Unkown
HY-155141 hCYP3A4-IN-1 Inhibitor / Unkown
HY-155262 Pomalidomide-5-C6-NH2 hydrochloride / Unkown
HY-15550S1 4'-Hydroxy diclofenac-13C6 / Unkown
HY-155593 JNK-1-IN-2 Inhibitor / Unkown
HY-156341S1 LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) (TFA) / Unkown
HY-156343S1 SNNYATHYAESVK-(Lys-13C6,15N2) (TFA) / Unkown
HY-156344S1 GLEWVAEIR-(Arg-13C6,15N4) (TFA) / Unkown
HY-156345S1 LPFTFGQGTK-(Lys-13C6,15N2) (TFA) / Unkown
HY-158251 BIBD-300 / Unkown
HY-158383 Pomalidomide-CO-C3-PEG4-C6-NH2 / Unkown
HY-158803 C6 Biotin glucosylceramide (d18:1/6:0) / Unkown
HY-159017 EM-12-Alkyne-C6-OMs / Unkown
HY-159018 Alkyne-C6-OMs / Unkown
HY-161012 RB-07-16 Inhibitor / Unkown
HY-161766 L687 Activator / Unkown
HY-162295 SARS-CoV-2-IN-83 Inhibitor / Unkown
HY-162342 Topoisomerase I inhibitor 14 Inhibitor / Unkown
HY-162370 CYP51-IN-16 Inhibitor / Unkown
HY-162522 SL-IN-1 Inhibitor / Unkown
HY-162644 Antitumor agent-170 Inhibitor / Unkown
HY-162782A V–C6–Bg-PhCl TFA Inhibitor / Unkown
HY-163422S PHSHPALTPEQK-(Lys-13C6,15N2) / Unkown
HY-163423S TELAEPTSTR-(Arg-13C6,15N4) / Unkown
HY-163424S SSVFVADPK-(Lys-13C6,15N2) / Unkown
HY-163425S AILNYVANK-(Lys-13C6,15N2) / Unkown
HY-163426S AFFGHYLYEVAR-(Arg-13C6,15N4) / Unkown
HY-163427S FNLEALVTHTLPFEK-(Lys-13C6,15N2) / Unkown
HY-163986 Pomalidomide-C2-NHCO-C6 / Unkown
HY-16561S1 Resveratrol-13C6 / Unkown
HY-16561S2 (E/Z)-Resveratrol-13C6 / Unkown
HY-169111 SHP2-IN-32 Inhibitor / Unkown
HY-169292 Antitumor agent-188 / Unkown
HY-17453S1 Salmeterol-13C6 xinafoate Agonist / Unkown
HY-17596S Closantel-13C6 Inhibitor / Unkown
HY-17598S Rafoxanide-13C6 Inhibitor / Unkown
HY-18341S1 Thyroxine hydrochloride-13C6 / Unkown
HY-18341S3 L-Thyroxine-13C6,15N / Unkown
HY-18341S4 L-Thyroxine-13C6-1 / Unkown
HY-18572S 2,4-D-13C6 Inhibitor / Unkown
HY-19542S Ceramide C6-d7 Inducer / Unkown
HY-19542S1 C6 Ceramide-d11 Inducer / Unkown
HY-19821S1 Fmoc-Ile-OH-13C6,15N / Unkown
HY-22306S β-D-Glucose pentaacetate-13C6 / Unkown
HY-34428S 4-Fluorobenzonitrile-13C6 / Unkown
HY-44630 VH 032 amide-alkylC6-acid / Unkown
HY-50896S1 Erlotinib-13C6 / Unkown
HY-66005S3 Acetaminophen-13C6 Inhibitor / Unkown
HY-76929S tert-Butyl 4-aminobenzoate-13C6 / Unkown
HY-78131S3 Ibuprofen-13C6 / Unkown
HY-79131S Fmoc-Phe-OH-13C6 / Unkown
HY-79576S2 NSC 88911-13C6 / Unkown
HY-A0070AS2 Liothyronine-13C6-1 Agonist / Unkown
HY-A0130S Sulfalene-13C6 Inhibitor ≥99.0% Unkown
HY-A0132S12 N-Acetyl-D-glucosamine-13C6 / Unkown
HY-A0161S Chlophedianol-13C6 / Unkown
HY-B0141S4 Estradiol-13C6 Agonist / Unkown
HY-B0141S7 rel-Estradiol-13C6 / Unkown
HY-B0166S8 L-Ascorbic acid-13C6-1 99.15% Unkown
HY-B0213S1 Sulfameter-13C6 Inhibitor / Unkown
HY-B0221S Amphotericin B-13C6 / Unkown
HY-B0263S1 Thiabendazole-13C6 Inhibitor / Unkown
HY-B0273S1 Sulfadiazine-13C6 Inhibitor / Unkown
HY-B0335S1 Tolfenamic acid-13C6 Inhibitor / Unkown
HY-B0337S2 Sulfadimethoxine-13C6 Inhibitor / Unkown
HY-B0375S1 Argatroban-13C6 hydrochloride Inhibitor / Unkown
HY-B0467AS Amoxicillin-13C6 Inhibitor / Unkown
HY-B0497BS Niclosamide-13C6 monohydrate / Unkown
HY-B0574S2 Mefenamic acid-13C6 Inhibitor / Unkown
HY-B0822S1 Fipronil-13C6 / Unkown
HY-B0843S Metalaxyl-13C6 Inhibitor / Unkown
HY-B0892S3 Benzyl alcohol-13C6 / Unkown
HY-B0925S Oxacillin-13C6 sodium Inhibitor / Unkown
HY-B0946S2 Sulfamonomethoxine-13C6 Inhibitor / Unkown
HY-B0947S1 Sulfanitran-13C6 Inhibitor / Unkown
HY-B1355AS1 Oxyphenbutazone-13C6 Inhibitor / Unkown
HY-B1409S Isosorbide dinitrate-13C6 / Unkown
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / Unkown
HY-B1431S1 Butylparaben-13C6 / Unkown
HY-B1436S1 Nifuroxazide-13C6 Inhibitor / Unkown
HY-B1456AS Fenoprofen-13C6(sodium salt hydrate) / Unkown
HY-B1779S5 Sucrose-13C6 / Unkown
HY-B1781S Sulfachloropyridazine-13C6 Inhibitor / Unkown
HY-B2156S1 Menaquinone-4-13C6 / Unkown
HY-B2236S1 DL-Lysine-13C6 hydrochloride / Unkown
HY-B2236S2 DL-Lysine-13C6,15N2 hydrochloride / Unkown
HY-D1433 FITC-C6-LEHD-FMK / Unkown
HY-D1573 C6 NBD Phytoceramide / Unkown
HY-D1575 C6 NBD Galactosylceramide / Unkown
HY-D1577 C6 NBD Lactosylceramide / Unkown
HY-D1749 C6 NBD L-threo-ceramide / Unkown
HY-E70037 GlcNAc kinase (EcNagK) / Unkown
HY-I0210S 4-Iodoaniline-13C6 / Unkown
HY-N0216S1 Benzoic acid-13C6 Inhibitor ≥98.0% Unkown
HY-N0304S1 L-DOPA-13C6 / Unkown
HY-N0378S2 D-Mannitol-13C6 / Unkown
HY-N0379S18 D-Mannose-13C6,d7 / Unkown
HY-N0455AS4 L-Arginine-13C6,15N4,d7 hydrochloride Activator / Unkown
HY-N0470S1 L-Lysine-13C6,15N2,d9 dihydrochloride Inhibitor / Unkown
HY-N0470S8 L-Lysine-13C6 hydrochloride / Unkown
HY-N0683S α-Vitamin E-13C6 Inhibitor / Unkown
HY-N0733S5 Glucosamine-13C6,15N hydrochloride / Unkown
HY-N0771S5 L-Isoleucine-13C6,15N,d10 / Unkown
HY-N0832S1 L-Histidine-13C6,15N3 Inhibitor / Unkown
HY-N0832S1A L-Histidine-13C6,15N3 hydrochloride / Unkown
HY-N10192 Aculene D Inhibitor / Unkown
HY-N11137 3′-Omethyl-5′-hydroxydiplacone Inhibitor / Unkown
HY-N1127S Tricin-d6 / Unkown
HY-N12396 Cyclosporin U / Unkown
HY-N1380S2 Guaiacol-13C6 / Unkown
HY-N1393S 2-Methoxybenzoic acid-13C6 / Unkown
HY-N1394S p-Anisic acid-13C6 Inhibitor / Unkown
HY-N7092S13 D-Fructose-13C6,d7 / Unkown
HY-N7123S1 Sulfacetamide-13C6 Inhibitor / Unkown
HY-N7147 Irisquinone / Unkown
HY-N7464 Jolkinolide E / Unkown
HY-N7745S2 Glucosylsphingosine-13C6 / Unkown
HY-N8462 6-O-Nicotinoylscutebarbatine G / Unkown
HY-N8588 Methyl ganoderate C6 / Unkown
HY-N9454 Garcinoic acid / Unkown
HY-P0014S2 Liraglutide-13C6,15N TFA / Unkown
HY-P2625S GLP-2(3-33) (Leu-13C6,15N) / Unkown
HY-P2625S1 GLP-2(3-33) (Leu-13C6,15N) (TFA) / Unkown
HY-P4596S H-Gly-Arg-OH (Arg-13C6,15N4) / Unkown
HY-P4596S1 H-Gly-Arg-OH (Arg-13C6,15N4) (TFA) / Unkown
HY-P5168S GPSVFPLAPSSK-13C6 / Unkown
HY-P5190S RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE / Unkown
HY-P5190S1 RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE TFA / Unkown
HY-P5201S VTSEGAGLQLQK-13C6,15N2 / Unkown
HY-P5201S1 VTSEGAGLQLQK-13C6,15N2 TFA / Unkown
HY-P5628 Termicin / Unkown
HY-RS01752 C6 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS05970 H3C6 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS05978 H4C6 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W001138S 4-Bromobenzaldehyde-13C6 / Unkown
HY-W007318S 2-Iodoaniline-13C6 / Unkown
HY-W008253S3 5-Hydroxyindole-3-acetic acid-13C6 / Unkown
HY-W008452S H-Tyr(3-I)-OH-13C6 / Unkown
HY-W008642S (Leu-13C6,15N)-Leu-OH TFA / Unkown
HY-W009048 Dicyclohexano-18-crown-6-ether / Unkown
HY-W009300S1 4-Hydroxyestrone-13C6 / Unkown
HY-W009597S 1,5-Dichloro-2,4-dinitrobenzene-13C6 / Unkown
HY-W010042S3 L-Glucose-13C6 / Unkown
HY-W010696AS Reverse T3-13C6 hydrochloride / Unkown
HY-W012530S Phenylpyruvic acid-13C6 sodium / Unkown
HY-W013186S1 Lansoprazole sulfide-13C6 / Unkown
HY-W013396S 4-Iodobenzoic Acid-13C6 / Unkown
HY-W013677S 4-Fluorobenzoic acid-13C6 / Unkown
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / Unkown
HY-W014375S1 Arginine-13C6,15N4,d7 hydrochloride / Unkown
HY-W014375S4 Arginine-13C6,15N4 hydrochloride / Unkown
HY-W014423S1 L-Histidine-13C6,15N3,d5 hydrochloride hydrate / Unkown
HY-W014423S2 L-Histidine-13C6 hydrochloride hydrate / Unkown
HY-W014632S 4-Trifluoromethylsalicylic acid-13C6 / Unkown
HY-W015198S 4-(Trifluoromethyl)benzoic acid-13C6 / Unkown
HY-W018386S 3-​Bromo-​L-​tyrosine-13C6 / Unkown
HY-W041171S 3-Chloro-L-tyrosine-13C6 / Unkown
HY-W050145S2 Levoglucosan-13C6 / Unkown
HY-W069721S1 N-Acetylsulfanilamide-13C6 / Unkown
HY-W092298S Methyl 4-(2-hydroxyethyl)benzoate-13C6,d2 / Unkown
HY-W100312S o-Toluidine-13C6 hydrochloride / Unkown
HY-W104549S 3,6-Dichloro-2-hydroxybenzoic acid-13C6 / Unkown
HY-W106014S [1,1'-Biphenyl]-3-amine-13C6 hydrochloride / Unkown
HY-W156511S Diacetylsulfanilamide-13C6 / Unkown
HY-W243018S 1,2:5,6-Di-O-isopropylidene-a-D-glucofuranose-1,2,3,4,5,6-13C6 / Unkown
HY-W269700S Ile-(Leu-13C6,15N)-OH TFA / Unkown
HY-W278861S Desoxy-Mequindox-13C6 / Unkown
HY-W280531S DNSAH-13C6 ≥99.0% Unkown
HY-W344468S Adipate-13C6 sodium / Unkown
HY-W440751 BP Lipid 112 / Unkown
HY-W440803 BP Lipid 218 / Unkown
HY-W584531 VH032-C6-NH-Boc / Unkown
HY-W768340 Sucrose-13C6-1 / Unkown
HY-W777456 Phenanthrene-13C6 / Unkown
HY-W777457 Anthracene-13C6 / Unkown
HY-W777535S Naphthalene-13C6 / Unkown
HY-W800749 BP Lipid 223 / Unkown
HY-W800777 6-(3-Hydroxypropylamino)hexyl 2-hexyldecanoate / Unkown
HY-Y0264S 4-Hydroxybenzoic acid-13C6 / Unkown
HY-Y0589S m-Cyanobenzoic acid-13C6 / Unkown
HY-Y0721S 3-Bromofluorobenzene-13C6 / Unkown
HY-Y0931S 3-Iodobenzoic Acid-13C6 / Unkown
HY-Y1027S1 2-Chlorobenzoic acid-13C6 / Unkown
HY-Y1636S1 L-Arginine-N-FMOC PBF-OH-13C6 / Unkown
HY-111491 Methiothepin Antagonist / Unkown
HY-114667 Lavendustin C6 Inhibitor / Unkown
HY-128417S4 alpha-D-glucose-13C6 / Unkown
HY-128417S5 alpha-D-glucose-13C6,d7 / Unkown
HY-131622S 7-Aminoclonazepam-13C6 / Unkown
HY-137222S 4',5-Dihydroxy Diclofenac-13C6 Inhibitor / Unkown
HY-139062 C6 Urea Ceramide / Unkown
HY-13948BS Angiotensin II human-13C6,15N TFA 98.11% Unkown
HY-143276 (S,S,R)-AHPC-C6-NH2 / Unkown
HY-143679S 4-(3',6'-Dimethyl-3'-heptyl)phenol diethoxylate-13C6 / Unkown
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride / Unkown
HY-149563 Thalidomide-5-O-C6-NH2 hydrochloride / Unkown
HY-150194S Fructose-glutamic acid-13C6 / Unkown
HY-151792 Pomalidomid-C6-PEG3-butyl-N3 / Unkown
HY-153542 AP-C6 Inhibitor / Unkown
HY-158656 3-Keto sphinganine (d6:0) (hydrochloride) / Unkown
HY-158992S SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA / Unkown
HY-158994S MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA / Unkown
HY-159077 H2N-C6-NH-CO-CH2-O-Ph-CH2-NH-Boc / Unkown
HY-161538 Lenalidomide-C6-Br / Unkown
HY-163992S VTMTRDTSISTAYMELSR-(Ile-13C6,15N) / Unkown
HY-163993S GMDRWGQGTLVTVSS-(Leu-13C6,15N) / Unkown
HY-165087 C6 Biotin ceramide (d18:1/6:0) / Unkown
HY-165975 (2S)-3-Keto sphinganine (d6:0) (hydrochloride) / Unkown
HY-166282 C6 NBD-L-threo-dihydrosphingosine / Unkown
HY-16637S5 Folic acid-13C6 / Unkown
HY-168132 Thalidomide-NH-C-C6H10-C-acid / Unkown
HY-17356S2 Fenofibrate-13C6 / Unkown
HY-19542A N-Hexanoyl-L-erythro-sphingosine / Unkown
HY-66008S2 N-Acetyl mesalazine-13C6 / Unkown
HY-79128S1 Fmoc-L-Lys (Boc)-OH-13C6,15N2 Inhibitor / Unkown
HY-B0122S Topiramate-13C6 / Unkown
HY-B0122SS1 Topiramate-13C6-1 / Unkown
HY-B0174AS Olsalazine-13C6 / Unkown
HY-B1941S1 4-tert-Octylphenol-13C6 / Unkown
HY-D1576 C6 NBD L-threo-dihydroceramide / Unkown
HY-N0455AS11 L-Arginine-13C6,d14 hydrochloride / Unkown
HY-N0771S9 L-Isoleucine-13C6,15N / Unkown
HY-N10004S 1-Deoxy-1-L-proline-D-fructose-13C6 / Unkown
HY-N3622 Corchoionoside C / Unkown
HY-P3207S DLPLTFGGGT-Lys-13C6,15N2 TFA / Unkown
HY-P6421S LGPLVEQG-Arg(13C6,15N4) TFA / Unkown
HY-P6422S LAVYQAGA-Arg(13C6,15N4) TFA / Unkown
HY-P6423S CLAVYQAGA-Arg(13C6,15N4) TFA / Unkown
HY-P6424S LGADMEDVCG-Arg(13C6,15N4) TFA / Unkown
HY-P6425S LCADMEDV-Arg(13C6,15N4) TFA / Unkown
HY-W010209S DL-Histidine-13C6,15N3 / Unkown
HY-W016814S (Z)-Aconitic acid-13C6 / Unkown
HY-W050154S Kojic acid-13C6 Inhibitor / Unkown
HY-W101298S (Leu-13C6,15N)-Ile-OH TFA / Unkown
HY-W145482S1 3-O-Methyl-D-glucopyranose-13C6 / Unkown
HY-W440787 BP Lipid 142 / Unkown
HY-W585890S Benzo[pqr]tetraphen-3-ol-13C6 / Unkown
HY-W585933S Fructose-alanine-13C6 / Unkown
HY-W585934S Fructose-phenylalanine-13C6 / Unkown
HY-W585956 Triclocarban-13C6 / Unkown
HY-W590666 N-Hexanoyldihydrosphingosine / Unkown
HY-W721295S N-(1-Deoxy-D-fructos-1-yl)-L-methionine-13C6 / Unkown
HY-W738582S N-(1-Deoxy-D-fructos-1-yl)​-L-threonine-13C6 / Unkown
HY-W749012 (2,4,6-Trichlorophenoxy)acetic acid-13C6 / Unkown
HY-W777418 Isosorbide mononitrate-13C6 Inhibitor / Unkown
HY-W777526 Nitisinone-13C6 / Unkown
HY-W777581 4-tert-Octylphenol-diethoxylate-13C6 / Unkown
HY-W777582 4-tert-Octylphenol monoethoxylate-13C6 / Unkown
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / Unkown
HY-W777681 Triflusal-13C6 / Unkown
HY-W778225 Vanillic acid-13C6 / Unkown
HY-W780150 1-Bromobenzene-13C6 / Unkown
HY-W793608S N-(1-Deoxy-D-fructos-1-yl)-L-asparagine-13C6 / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99832 Cosfroviximab 95.00% Unkown

Orthologs Information

Species Symbol Source ID
Bos taurus C6 VGNC VGNC:52722
Felis catus C6 VGNC VGNC:60233
Rattus norvegicus C6 RGD RGD:2238
Canis familiaris C6 VGNC VGNC:38598
Macaca mulatta C6 VGNC VGNC:70477
Mus musculus C6 MGD MGI:88233
Macaca fascicularis C6 NCBI NCBI:102116032
Others C6 NCBI